BNY is the quiet compounder of the custody world: a record $5.7B revenue quarter in July, fees up 10.8%, net interest income up 20.2%, and a guidance raise on every line that matters: full-year revenue to +10-11%, NII to +12-13%, roughly 400 basis points of positive operating leverage. The board underlined it with a 19% dividend hike. The chart matches the story: a three-week base above a rising EMA stack, with the late-July flush to 151.68 bought back in two sessions. Two counterweights. The upside to the 52-week high at 163.77 is modest from here, so an at-market buyer is paid poorly against a proper stop. And the insider tape carries a footnote worth reading correctly: the CFO sold 31,800 shares on July 29 (about $4.9M, roughly a tenth of his direct stake) two weeks after the raise, four other officers sold about $6.6M in April, and there is not a single open-market buy on the tape. The CEO's July filing at 161.07, easy to misread as a top-tick sale, was a transfer into a family trust with no change in ownership. None of this breaks the thesis; it says the easy part of the move is behind. The trade is the retest of the EMA20 zone near 155.50, stop under the July flush, first target the annual high.
BNY is the world's largest custodian, safekeeping and servicing roughly $50 trillion of assets, clearing US Treasuries, and running Pershing (wealth infrastructure) and a $2T asset manager. The model is fee-heavy with an NII kicker: scale platforms that grow with market levels and activity, plus a balance sheet that reprices with rates. The July quarter showed both engines running: record revenue, fees and NII both double-digit — and management raised the full-year outlook on revenue, NII and operating leverage simultaneously.
| Metric | Value | Signal |
|---|---|---|
| Revenue (Q2) | $5.7B | Record |
| Fee Revenue (y/y) | +10.8% | Core engine |
| NII (y/y) | +20.2% | Rate kicker |
| ROE | 14.1% | Solid |
| Book Value / Share | $58.82 | P/B 2.69x |
| Forward PE | 15.4x | Premium custody |
| PEG | 1.32 | Reasonable |
| Dividend | $0.63/q | +19% raise |
| Quarter | EPS Actual | EPS Est. | Surprise | Revenue |
|---|---|---|---|---|
| Q3 2025 (cal.) | $1.91 | $1.77 | +7.9% | - |
| Q4 2025 (cal.) | $2.08 | $1.98 | +5.1% | - |
| Q1 2026 (cal.) | $2.25 | $1.93 | +17% | - |
| Q2 2026 (cal.) | $2.46 | $2.22 | +11% | - |
Five consecutive beats (Q2 2025 verified separately: 1.94 vs 1.74). The July 15 report gapped the stock +5.1% on twice normal volume — the market believed the raise. Next report: October 15, 2026, outside the trade window.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-29 | Dermot McDonogh (CFO) | Sell | 31,800 | ~$4.94M at avg $155.26 (tranches $153.78-156.68) — about 11% of his stake; retains ~248,700 shares (~$39M) plus unvested awards |
| 2026-07-16 | Robin Vince (CEO) | Transfer | 24,833 | Moved into a family trust at $161.07 (Form 4 code J, exchange for equal-value assets) — no change in beneficial ownership; not an open-market sale |
| 2026-04-17 | General Counsel + officers cluster | Sell | 48,091 | ~$6.6M combined (GC ~$4.1M at ~$136.50, SEVP ~$1.7M, plus Controller and another officer at ~$136-137), the day after the Q1 print |
Zero open-market buys against eight sale transactions in 120 days. Read it precisely: the CFO's headline print is a partial trim — he keeps roughly ninety percent of his stake — and the CEO's July filing was a family-trust transfer, not a sale. Still, officers chose to sell at ~136 in April and again at 154-157 in July, and nobody bought. That is mild distribution, not abandonment; it argues against chasing strength, not against the position itself.
Net share count shrinking: $1.1B of stock repurchased in Q2 alongside the 19% dividend raise, more than absorbing SBC. One footnote: BNY keeps a shelf registration on file (October 2024) and drew on it in February 2026 for a $500M Series M preferred issue — routine large-bank funding that ranks ahead of common for dividends but adds zero new common shares. No ATM program, no convertible, no common equity offering on file.
Low and falling: no structured bear position. (The stats-feed short figure is unreliable for this name; the verified FINRA reading is used.)
| RSI (14) | 55.6 |
| EMA 20 | $154.96 |
| EMA 50 | $148.83 |
| EMA 200 | $128.85 |
| MACD | 2.476 |
| Signal | 3.260 |
| ATR (14) | $3.46 |
The July 15 guidance gap (+5.1% on 2x volume) built a three-week base between 152.50 and 160.86 under the annual high at 163.77. The July 29 flush to 151.68 (the CFO-sale session) was bought back within two sessions. Price now trades in the upper third of the range, 2.2% above the EMA20, with MACD below its signal: consolidation, not acceleration. The clean entry is the EMA20 retest near 155. A confirmed close above 160.86 puts the annual high in play, but from there the headroom to 163.77 is less than one ATR — treat it as confirmation for an existing position, not an entry.
Balance-sheet risk is minimal: no dilution, low short interest, capital returning. The live risks are positioning ones: senior insiders selling into strength, momentum cooling inside the base, and a premium multiple that assumes the guide is met.
Every line of the July report argues for higher — record revenue, double raise, 19% dividend hike. The tape argues for patience: insiders trimmed into strength and momentum is resting. The retest entry takes both seriously: own the raise near the average, stop under the flush the base already absorbed.
Run the arithmetic before the market runs it for you. From today's 158.40 with the stop at 151, you risk $7.40 to make $5.30 to the first target — about 0.7-to-1. From 155.50 the same trade pays 1.8-to-1. The setup does not change; the price you pay for it does. Set the limit in the 155 zone and let it come to you, or let it go.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from real-time market data, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.